Regulatory Landscape: Standardizing the Wild West
The "Wild West" era of mental health apps ended in 2024. By 2025, the FDA (US) and MHRA (UK) have established strict Qualification and Classification frameworks. Devices and software are categorized based on risk:
Class I: Low-risk wellness/meditation apps (self-certified).
Class II/III: High-risk diagnostic or treatment tools (requiring clinical trials).
In 2025, the "Deterioration Rate" (patients getting worse while using an app) is now a mandatory reporting metric. This focus on clinical safety has forced thousands of low-quality "wellness" apps out of the market, leaving a more robust, evidence-based selection for consumers and clinicians.
1 View